View in EDS

568PPersonalized medicine in individuals living with late onset Pompe disease (LOPD): urine glucose tetrasaccharide (Glc4) as a predictive biomarker during follow-up.

Saved in:
Bibliographic Details
Title: 568PPersonalized medicine in individuals living with late onset Pompe disease (LOPD): urine glucose tetrasaccharide (Glc4) as a predictive biomarker during follow-up.
Authors: Lessard, L.1 (AUTHOR), Chitimus, D.2,3,4 (AUTHOR), Froissart, R.5 (AUTHOR), Bouhour, F.6,7,8 (AUTHOR), Hamroun, D.9 (AUTHOR), Laforêt, P.3 (AUTHOR), Pettazzoni, M.5 (AUTHOR)
Source: Neuromuscular Disorders. 2025 Supplement, Vol. 53, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 193863503
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 568PPersonalized medicine in individuals living with late onset Pompe disease (LOPD): urine glucose tetrasaccharide (Glc4) as a predictive biomarker during follow-up.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Lessard%2C+L%2E%22">Lessard, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chitimus%2C+D%2E%22">Chitimus, D.</searchLink><relatesTo>2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Froissart%2C+R%2E%22">Froissart, R.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bouhour%2C+F%2E%22">Bouhour, F.</searchLink><relatesTo>6,7,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hamroun%2C+D%2E%22">Hamroun, D.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Laforêt%2C+P%2E%22">Laforêt, P.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pettazzoni%2C+M%2E%22">Pettazzoni, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Neuromuscular+Disorders%22">Neuromuscular Disorders</searchLink>. 2025 Supplement, Vol. 53, pN.PAG-N.PAG. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=193863503
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.nmd.2025.106124
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: N.PAG
    Titles:
      – TitleFull: 568PPersonalized medicine in individuals living with late onset Pompe disease (LOPD): urine glucose tetrasaccharide (Glc4) as a predictive biomarker during follow-up.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lessard, L.
      – PersonEntity:
          Name:
            NameFull: Chitimus, D.
      – PersonEntity:
          Name:
            NameFull: Froissart, R.
      – PersonEntity:
          Name:
            NameFull: Bouhour, F.
      – PersonEntity:
          Name:
            NameFull: Hamroun, D.
      – PersonEntity:
          Name:
            NameFull: Laforêt, P.
      – PersonEntity:
          Name:
            NameFull: Pettazzoni, M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2025 Supplement
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09608966
          Numbering:
            – Type: volume
              Value: 53
          Titles:
            – TitleFull: Neuromuscular Disorders
              Type: main
ResultId 1